Conference Coverage
Conference Coverage
Apremilast’s positive study results made it the talk of ACR 2013
Major finding: After 16 weeks of treatment, the investigational drug apremilast achieved an ACR20 response of 29.2% at 20 mg twice daily as first-...
Conference Coverage
Depression accounts for psoriatics’ increased MI risk
Major finding: Patients with psoriasis or psoriatic arthritis who developed comorbid depression had a highly significant 80% increased risk of...
Conference Coverage
Cyclophosphamide and rituximab combo reduced severe lupus flares
Major finding: Patients with severe recurrent systemic lupus erythematosus collectively had 38 lupus flares, including 26 with renal involvement,...
Conference Coverage
Psoriasis drug research aimed at severe disease
Conference Coverage
Women’s sexuality diminished by psoriasis
Conference Coverage
Treat-to-target approach for psoriatic arthritis found beneficial
Major finding: At 48 weeks, a higher proportion of psoriatic arthritis patients in the intensive management group achieved ACR70, compared with...
Conference Coverage
Wet dressings work for pruritus when other options fail
Conference Coverage
Patient education on heart failure risk is crucial in psoriasis
Conference Coverage
Don’t brush off topical therapies for psoriasis
Conference Coverage
Antirheumatic drugs don’t boost surgical infection risk
Major finding: Rheumatoid arthritis patients who remained on their antirheumatic medication while they underwent various types of surgery did not...